Medibank today announced that non-executive directors Christine O’Reilly and Peter Hodgett will be retiring from the Board at the conclusion of the Annual General Meeting on 18 November 2021, having chosen not to stand for re-election.
Ms O’Reilly has been member of the Board since March 2014. She is the Chairman of the Audit Committee, and a member of the Risk Management Committee and the Nomination Committee.
Mr Hodgett was appointed a director in June 2013. He is the Chairman of the Investment and Capital Committee, and a member of the Audit Committee and the Nomination Committee.
Medibank Chairman Mike Wilkins said both directors had played a critical role in Medibank’s transformation over the past eight years.
“I would like to take this opportunity to thank both Christine and Peter for their valuable contribution to our company during their time as directors. They both joined the Board prior to Medibank’s listing on the Australian Securities Exchange and helped guide the business through its transition from government-owned business to privatised company.
“As Chairman of the Audit Committee, Christine has brought her extensive financial and operational experience to Medibank and we have benefited greatly from her insights and contribution for over seven years.
“In his role as Chairman of the Investment and Capital Committee, Peter has had a significant influence on the company’s capital framework and has been instrumental in Medibank’s adoption of more sustainable investment practices, including overseeing the development of Medibank’s Responsible Investment Policy.
“Medibank is a stronger organisation for both Christine and Peter’s contribution, and we wish them all the best for the future.”
The Board has now begun the process to replace the two directors.
This announcement has been approved for release by the Chairman.
For further information please contact: For media
Senior Executive, External Affairs
M: +61 439 763 856